Expression of vascular endothelial growth factor (VEGF), hypoxia inducible factor-1α (HIF-1α), and microvessel density in endometrial tissue in women with adenomyosis

International Journal of Gynecological Pathology

Volumn 28, Issue 2, 2009, Pages 157-163

  Goteri, Gaia ^a   Lucarini, Guendalina ^a   Montik, Nina ^a   Zizzi, Antonio ^a   Stramazzotti, Daniela ^a   Fabris, Guidalberto ^a   Tranquilli, Andrea Luigi ^a   Ciavattini, Andrea ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Adenomyosis; Angiogenesis; CD34; HIF 1 ; VEGF

Indexed keywords

CD34 ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN;

ADENOMYOSIS; ADULT; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIUM; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROVASCULATURE; OVARY CYST; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADICAL HYSTERECTOMY;

ADULT; ENDOMETRIOSIS; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; MICROVESSELS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; UTERINE DISEASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 68349129800     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/PGP.0b013e318182c2be     Document Type: Article

References (34)

1. Leyendecker G, Herbertz M, Kunz G, et al. Endometriosis results from the dislocation of basal endometrium. Hum Reprod 2002;17:2725-2736 (Pubitemid 35174128)
2. Ferenczy A. Pathophysiology of adenomyosis. Hum Reprod Update 1998;4:312-322
3. Lei ZM, Rao CV, Lincoln SR, et al. Increased expression of human chorionic gonadotropin/human luteinizing hormone receptors gene in adenomyosis. J Clin Endocrinol Metab 1993;76:763-768 (Pubitemid 23086502)
4. Yamamoto T, Noquchi T, Tamura T, et al. Evidence for estrogen synthesis in adenomyotic tissues. Am J Obstet Gynecol 1993;169:734-738 (Pubitemid 23290202)
5. Takahashi K, Nagata H, Kitao M. Clinical usefulness of determination of estradiol level in menstrual blood for patients with endometriosis. Nippon Sanka Fujinka Gakkai Zasshi 1989;41:1849-1850 (Pubitemid 20037495)
6. Hever A, Roth RB, Hevezi PA, et al. Molecular characterization of human adenomyosis. Mol Human Reprod 2006;12:737-748
7. Mori T, Nagasawa H, Ohta Y. Prolactin and uterine adenomyosis in mice. In: Nagasawa H, ed. Prolactin and Lesions in Breast, Uterine and Prostate. FL: CRC Press; 1989:123-139
8. Yamashita M, Mori T. Disturbed cell arrangement, increased cell membrane permeability and apoptotic cell death occur in uterine tissues in mice. Zool Sci 1997;14:659-664 (Pubitemid 127138714)
9. Zhou YF, Mori T, Kudo H, et al. Effects of angiogenesis inhibitor TNP-470 on the development of uterine adenomyosis in mice. Fertil Steril 2003;80:788-794 (Pubitemid 37152395)
10. Ota H, Igarashi S, Tanaka T. Morphometric evaluation of stromal vascularization in the endometrium in adenomyosis. Hum Reprod 1998;13:715-719 (Pubitemid 28171975)
11. Obermair A, Bancher-Todesca D, Bilgi S, et al. Correlation of vascular endothelial growth factor expression and microvessel density in cervical intraepithelial neoplasia. J Nat Cancer Inst 1997;89:1212-1217 (Pubitemid 27350031)
12. Fina I, Molgaard HV, Robertson D, et al. Expression of the CD34 gene in vascular endothelial cells. Blood 1990;75:2417-2426 (Pubitemid 20202322)
13. Li T, Li YG, Pu MD. Matrix metalloproteinase-2 and -9 expression correlated with angiogenesis in human adenomyosis. Gynecol Obstet Invest 2006;62:229-235 (Pubitemid 44763191)
14. Risau W. Mechanisms of angiogenesis. Nature 1997;368:671-674
15. Healy DL, Rogers PA, Hii L, et al. Angiogenesis: a new theory for endometriosis. Hum Reprod Update 1998;4:736-740
16. McLaren J. Vascular endothelial growth factor and endometriotic angiogenesis. Hum Reprod Update 2000;6:45-55. (Pubitemid 30099342)
17. Sugino N, Kashida S, Karube-Harada A, et al. Expression of vascular endothelial growth factor (VEGF) and its receptors in human endometrium throughout the menstrual cycle and in early pregnancy. Reproduction 2002;123:379-387 (Pubitemid 34223884)
18. Smith SK. Angiogenesis and reproduction. BJOG 2001;108:777-783
19. Torry DS, Torry RJ. Angiogenesis and the expression of vascular endothelial growth factor in endometrium and placenta. Am J Reprod Immunol 1997;37:21-29 (Pubitemid 27075965)
20. Brenner RM, Slayden OD. Cyclic changes in the primate oviduct and endometrium. In: Knobil E, Neill JD, eds. The Physiology of Reproduction. New York: Raven Press; 1994:541-569
21. Niklaus AL, Aberdeen GW, Babischkin JS, et al. Effect of estrogen on vascular endothelial growth/permeability factor expression by glandular epithelial and stromal cells in the baboon endometrium. Biol Reprod 2003;68:1997-2004. (Pubitemid 36686989)
22. Albrecht ED, Aberdeen GW, Niklaus AL, et al. Acute temporal regulation of vascular endothelial growth/permeability factor expression and endothelial morphology in the baboon endometrium by ovarian steroids. J Clin Endocrinol Metab 2003;88:2844-2852 (Pubitemid 36724466)
23. Semenza GL, Nejfelt MK, Chi SM, et al. Hypoxia-inducible nuclear factors bind to an enhancer element located 3′ to the human erythropoietin gene. Proc Natl Acad Sci U S A 1991;88:5680-5684
24. Semenza GL, Agani F, Feldser D, et al. Hypoxia, HIF-1, and the pathophysiology of common human diseases. Adv Exp Med Biol 2000;475:123-130
25. Molitor JJ. Adenomyosis: a clinical and pathological appraisal. Am J Obstet Gynecol 1971;110:275-284
26. Wells M. Recent advances in endometriosis with emphasis on pathogenesis, molecular pathology, and neoplastic transformation. Int J Gynecol Pathol 2004;23:316-320 (Pubitemid 39299019)
27. Na YJ, Yang SH, Baek DW, et al. Effects of peritoneal fluid from endometriosis patients on the release of vascular endothelial growth factor by neutrophils and monocytes. Hum Reprod 2006;21:1846-1855
28. Bourlev V, Volkov N, Pavlovitch S, et al. The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions. Reproduction 2006;132:501-509 (Pubitemid 44524514)
29. Goteri G, Lucarini G, Filosa A, et al. Immunohistochemical analysis of vascular endothelial growth factor cellular expression in ovarian endometriomata. Fertil Steril 2004;81:1528-1533 (Pubitemid 38748994)
30. Schindl M, Birner P, Obermair A, et al. Increased microvessel density in adenomyosis uteri. Fertil Steril 2001;75:131-135 (Pubitemid 32041234)
31. Zhang J, Salamonsen LA. Expression of hypoxia-inducible factors in human endometrium and suppression of matrix metalloproteinases under hypoxic conditions do not support a major role for hypoxia in regulating tissue breakdown at menstruation. Hum Reprod 2002;17:265-274 (Pubitemid 34168425)
32. Sivridis E, Giatromanolaki A, Gatter KC, et al. Association of hypoxia-inducible factors 1α and 2α with activated angiogenic pathways and prognosis in patients with endometrial carcinoma. Cancer 2002;95:1055-1063 (Pubitemid 34925357)
33. Koos RD, Kazi AA, Roberson MS, et al. New insight into the transcriptional regulation of vascular endothelial growth factor expression in the endometrium by estrogen and relaxin. Ann N Y Acad Sci 2005;1041:233-247
34. Becker CM, Rohwer N, Funakoshi T, et al. 2-methoxyestradiol inhibits hypoxia-inducible factor-1 (alpha) and suppresses growth of lesions in a mouse model of endometriosis. Am J Pathol 2008;172:534-544 (Pubitemid 351282038)